(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration.
产品中实际含有多少
暂无产品标示该成分含量。
含该成分的产品中,0 款将其列在 1% 线之前,2 款列在之后(通常不超过 1%)。
含有此成分的产品
已确认 2 款中的 2 款 · 按含量充足程度排序
定义
美国FDA 物质登记 · UNII KD8QND6427 · 登记名称 DIHYDROMYRICETIN · 单一化学物质
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as an antioxidant, a metabolite and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin.
来源: PubChem
化妆品中的作用
保持肌肤良好状态(CosIng 泛分类)SKIN CONDITIONING
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 ジヒドロミリセチン: 本品は、次の化学式で表される芳香族化合物である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
DIHYDROMYRICETININCI다이하이드로미리세틴韩国标示名称(食药处标准名)ジヒドロミリセチン日本标示名称
- CAS No.化学物质登记号
- 27200-12-0
- DTXSID美国EPA化学品编号
- DTXSID50181676
- DTXCID美国EPA化合物编号
- DTXCID90104167
- IUPAC
- (2R,3R)-3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one
- 分子式
- C15H12O8
- 分子量
- 320.253 g/mol
产品实际使用的用途
相关文献
- Preparation and efficacy validation of dihydromyricetin nanoliposomes. · 2026
- Dihydromyricetin, the active component of rattan tea alleviates symptoms of systemic sclerosis and atopic dermatitis through modulation of RORγt and IL17A production in T cells. · 2025
- Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization · 2025
- Development of pectin/chitosan-based electrospun biomimetic nanofiber membranes loaded with dihydromyricetin inclusion complexes for wound healing application. · 2024
- A Poloxamer 407/chitosan-based thermosensitive hydrogel dressing for diabetic wound healing via oxygen production and dihydromyricetin release. · 2024